Day: January 5, 2022

VinFast Launches VinFirst NFT for EV’s Early-Bird Reservation

VinFast LOS ANGELES, Jan. 05, 2022 (GLOBE NEWSWIRE) — VinFast, the global electric vehicle (EV) brand owned by Vingroup – the largest private conglomerate in Vietnam with a total capitalization of 34.9 billion USD from three publicly traded companies (as of Nov 3, 2021) – has partnered with AAG Ventures and Harmony to announce a […]

Read more

Neeyamo Has Been Recognized as an Innovator in Avasant’s Global Hire-to-Retire Business Process Transformation 2021-22 RadarView

LOS GATOS, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) — Neeyamo Inc., a leading technology-enabled global payroll and HR services provider for multinational and micro-multinational corporations worldwide, has been recognized as an Innovator in Avasant’s maiden Global Hire-to-Retire Business Process Transformation 2021-22 RadarView. Avasant is a management consulting firm specializing in

Read more

Companies reduce emissions by up to 19% through digital tools, new report from Schneider Electric and CNBC shows

70% of emissions reduction are achievable with existing, proven and competitive technologies1 Swire Properties, IBM, Jacobs, IHG Hotels, and Tata Power share benefits of digital innovation Artificial intelligence, machine learning, blockchain, and 3-D modeling are key to supporting existing transformations as viable solutions to overcome climate challenges Rueil-Malmaison (France), January

Read more

Junshi Biosciences and DotBio Announce Collaboration to Develop Next-Generation Antibody Therapy with DotBody Module

SHANGHAI, China and SINGAPORE, Jan. 05, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biociences Co., Ltd (“Junshi Biosciences”, HKEX: 1877, SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and DotBio Pte. Ltd (“DotBio”), a biotech company specialized in next generation antibody therapies,

Read more

Conagen Successfully Develops Antioxidant Kaempferol by Precision Fermentation

Bedford, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — Conagen, the Massachusetts-based biotechnology innovator, announced the successful development of antioxidant kaempferol produced by state-of-the-art, proprietary, precision fermentation. As a biotechnology company specializing in developing commercially valuable molecules for its partners and clients, Conagen’s kaempferol enables brands in nutrition, beauty, and personal

Read more

Recent News

KING, QUEEN EXTEND LABOUR DAY WISHES

KUALA LUMPUR, In conjunction with the Labour Day celebration today, the King and Queen of Malaysia, His Majesty Sultan Ibrahim and Her Majesty Raja Zarith Sofiah, have conveyed their